Follow-The-Filings

Security · featured owners

CABA Cabaletta Bio Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 1.1%
  • $12M
  • 1 add

CABA (Cabaletta Bio Inc.) is held in 1 featured 13F book as of 2026 Q2. James Silverman - Opaleye Management is the largest tracked holder by portfolio weight (1.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman add 1.1%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 1.1% Add +180.0% 3,863,800 $12M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,2.02,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jun 9, 2026 · 5 forms Filing Doc
4 Period Mar 2, 2026 · 6 forms Filing Doc
4 Period Jan 21, 2026 · 8 forms Filing Doc

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$67.68M -$115.86M -$167.86M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $244.49M $166.68M $138.87M
Total non-current assets * $9.16M $18.37M $26.21M
Total assets $253.65M $185.05M $165.08M
Total current liabilities $15.99M $27.09M $50.15M
Total non-current liabilities * $1.46M $5.62M $2.88M
Total equity $236.2M $152.34M $112.05M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.55M -$88.22M -$131.08M
Cash from investing -$22.45M $47.29M -$50.27M
Cash from financing $187.63M $11.68M $100.35M
Net change in cash * $111.63M -$29.28M -$80.98M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders